Site-Specific and Targeted Therapy Based on Molecular Profiling by Next-Generation Sequencing for Cancer of Unknown Primary Site: A Nonrandomized Phase 2 Clinical Trial - Hayashi, H; Takiguchi, Y; Minami, H (JAMA Oncol, 2020)
et al.